The improvement of first-phase insulin response is related to long-term glycemic control in newly diagnosed Type 2 diabetic patients by continuous subcutaneous insulin infusion(CSII)

被引：0
|
作者：
Xu, W [1 ]
Li, YB [1 ]
Liao, ZH [1 ]
Yao, B [1 ]
Chen, XH [1 ]
Weng, JP [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Peoples R China
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
808
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [21] Improvement of -cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control
    Choi, Soo-Bong
    Lee, Jun-Ho
    Lee, Ju-Han
    Kim, Seonguk
    Han, Sang-Don
    Kim, Ick-Hee
    Noh, Yun-Hee
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2013, 29 (06) : 473 - 482
  • [22] LONG-TERM GLYCEMIC CONTROL BY ALTERNATIVE REGIMENS IN A FEASIBILITY STUDY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    KNIGHT, G
    BOULTON, AJM
    DRURY, J
    WARD, JD
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1986, 3 (07): : 355 - 358
  • [23] Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease
    Li, Qing
    Wang, Luan
    Xiao, Lin
    Wang, Zhongchao
    Wang, Fang
    Yu, Xiaolong
    Yan, Shengli
    Wang, Yangang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (02) : 612 - 618
  • [24] Influential factors affecting glycemic control in type I diabetes patients on continuous subcutaneous insulin infusion (CSII) therapy
    Rembert, J
    Elchoufi, L
    Lilavivat, U
    DIABETES, 1999, 48 : A354 - A354
  • [25] FEASIBILITY AND EFFICACY OF LONG-TERM TREATMENT BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) IN INSULIN-DEPENDENT DIABETES
    VANBALLEGOOIE, E
    REITSMA, WD
    SLUITER, WJ
    DOORENBOS, H
    NETHERLANDS JOURNAL OF MEDICINE, 1984, 27 (05): : 185 - 192
  • [26] LONG-TERM TREATMENT OF TYPE-I DIABETES-MELLITUS BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
    SCHROER, G
    SONNENBERG, GE
    CHANTELAU, E
    BERGER, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (02) : 38 - 38
  • [27] Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
    Feng-fei Li
    Wen-li Zhang
    Bing-li Liu
    Dan-feng Zhang
    Wei Chen
    Li Yuan
    Mao-yuan Chen
    Xiao-fang Zhai
    Jin-dan Wu
    Xiao-fei Su
    Lei Ye
    Hong-yong Cao
    Jian-hua Ma
    Scientific Reports, 8
  • [28] Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
    Li, Feng-fei
    Zhang, Wen-li
    Liu, Bing-li
    Zhang, Dan-feng
    Chen, Wei
    Yuan, Li
    Chen, Mao-yuan
    Zhai, Xiao-fang
    Wu, Jin-dan
    Su, Xiao-fei
    Ye, Lei
    Cao, Hong-yong
    Ma, Jian-hua
    SCIENTIFIC REPORTS, 2018, 8
  • [29] Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function
    Li, YB
    Xu, W
    Liao, ZH
    Yao, B
    Chen, XH
    Huang, ZM
    Hu, GL
    Weng, JP
    DIABETES CARE, 2004, 27 (11) : 2597 - 2602
  • [30] Effects of Sitagliptin With Continuous Subcutaneous Insulin Infusion (CSII) on Bone Formation Markers in Newly-Diagnosed Type 2 Diabetes
    Song, Yingxiang
    Ye, Xiao
    Xing, Yubo
    Wang, Lijun
    Hua, Yanyin
    DIABETES, 2013, 62 : A670 - A670
12345